There is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the …
Read More
A study of radio-frequency catheter ablation by the Agency for Healthcare Research and Quality (AHRQ) was one of the first government-mandated Comparative Effectiveness Research (CER) studies released. The report found that catheter ablation appears effective up to one year after the procedure, but more research is needed into longer-term success as well as the impact …
Read More
Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong. Learn more: Medtronic Clinical Trial …
Read More
We continue to learn more about the family connection in atrial fibrillation. A second gene was just found that increases the risk of afib and stroke. At least one third of those of European descent carry one copy of the newly-discovered variant in the ZFHX3 gene and have a 20% increase in risk of afib …
Read More
UPDATED 6-30-09: Study is now complete. An afib research study is looking for afib patients who are near San Francisco, Cincinnati, or New Jersey/New York and who have taken certain anti-arrhythmic medications (Flecainide, Rythmol, Propafenone, and similar). They are offering an honorarium for your time. Find out if you qualify at: Atrial Fibrillation Research Study …
Read More